These findings underscore the importance of accurately quantifying CP volume to better understand its role in AD progression, to potentially serve as an imaging biomarker for cognitive decline, and to facilitate accurate regional functional measures like blood flow and permeability (Bouzerar et al., 2013; Tadayon et al., 2020). This evidence concerns the gene CP and Alzheimer disease.